Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Anderson LR et al. – Reversal of the BAG–1–associated survival phenotype by the mitogen–activated kinase/ERK kinase inhibitor, U0126, implicates the RAF–1–extracellular signal–regulated kinase signaling pathway as a major mediator of BAG–1's effects in this model. As BAG–1 expression is often elevated in preinvasive breast cancers, these findings support a possible role for BAG–1 as an early contributor to the malignant process in the breast.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address